🔊CEOInterviews

Tim Czartoski on cybersecurity

From The Usefulness of Technology – A Perspective from Industry by Tim Czartoski · · Anterior Hip Foundation

“Security is incredibly important. You can imagine a company like Johnson & Johnson—we're a target for pretty much everything, whether it's lawsuits, liability, or because we're an international Fortune 500 company. People come after us, so we have to make sure we're secure in our data systems.”

Tim Czartoski
President of U.S. Surgical and Global Product & Enabling Technologies, ENOVIS CORP
Policy Impact cybersecuritycorporate riskdata protection

On , Tim Czartoski, President of U.S. Surgical and Global Product & Enabling Technologies at ENOVIS CORP, spoke about cybersecurity during The Usefulness of Technology – A Perspective from Industry by Tim Czartoski on Anterior Hip Foundation.

The Usefulness of Technology – A Perspective from Industry by Tim Czartoski
Watch on YouTube
The Usefulness of Technology – A Perspective from Industry by Tim Czartoski
Anterior Hip Foundation
Watch on YouTube
A talk by Tim Czartoski of DePuy Synthes entitled The Usefulness of Technology – A Perspective from Industry at the 2022 AHF ...
Tim Czartoski

About Tim Czartoski

President of U.S. Surgical and Global Product & Enabling Technologies · ENOVIS CORP

Tim Czartoski, president of U.S. Surgical and Global Product & Enabling Technologies at Enovis, delivered a talk in September 2022 at the AHF conference titled "The Usefulness of Technology – A Perspective from Industry." During the presentation, he discussed how companies evaluate and invest in medical technology. He noted that the price of technology tends to decrease over time, using the example of a Toyota Camry whose cost remained around $21,000 over 20 years despite significant digital upgrades. Czartoski stated that traditional valuation models like discounted cash flow are inadequate for technology because indirect returns are difficult to predict, and companies must instead place bets on which technologies will shift the "s-curve" of innovation. Czartoski also addressed challenges related to data in healthcare. He said that 90 percent of big data projects fail due to a lack of clear definitions for data needs and use cases. He emphasized the importance of data integrity, security, and patient ownership of data, and noted that regulatory pathways through the FDA remain a challenge. He described Johnson & Johnson's approach to innovation as relying on an open platform that includes global innovation centers

Profile compiled from Tim Czartoski's verified public interviews and appearances. See all quotes & transcripts →

More from Tim Czartoski ENOVIS CORP (ENOV) Full Transcript Explore All Executives